In ₹ Crore except Per Share Latest Annual | HIKAL FY26 | PANACEABIO FY26 | DCAL FY26 | SAIPARENT FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | — | ◆ 26.88× | 119.50× | 73.19× | |
| P/B | 2.41× | 2.87× | ◆ 0.39× | 4.65× | 2.87× -16% | |
| EV/EBITDA | 16.16× | ◆ -501.02× | 8.12× | 56.96× | 8.12× +99% | |
| Market Cap | ₹2,891 Cr | ₹2,378 Cr | ₹2,621 Cr | ₹2,302 Cr | ₹2,378 Cr +22% | |
| Growth | ||||||
| Revenue CAGR 3Y | -5.40% | ◆ 11.63% | 6.71% | — | 9.17% -159% | |
| Revenue CAGR 5Y | -0.09% | 0.47% | ◆ 8.93% | — | 4.70% -102% | |
| Revenue YoY (latest Q) | 5.89% | ◆ 19.72% | -4.29% | — | 7.71% -24% | |
| Net Income YoY (latest Q) | ◆ 66.96% | -44.44% | -347.24% | — | -195.84% +134% | |
| Profitability | ||||||
| EBITDA Margin | 12.87% | -0.73% | ◆ 19.29% | 10.16% | 10.16% +27% | |
| Net Income Margin | -2.85% | -1.12% | 3.32% | ◆ 3.74% | 3.32% -186% | |
| Return on Common Equity | -4.07% | -0.65% | 1.46% | ◆ 2.88% | 1.46% -379% | |
| Return on Capital Employed | ◆ 3.36% | -4.13% | 2.36% | 2.57% | 2.36% +42% | |
| Return on Assets | -2.06% | -0.57% | 0.82% | ◆ 1.00% | 0.82% -351% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.57× | ◆ 0.03× | 0.42× | 0.65× | 0.42× +36% | |
| Interest Coverage | 0.91× | -6.23× | ◆ 1.30× | 1.18× | 1.18× -23% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,713 Cr | ₹640 Cr | ₹2,932 Cr | ₹381 Cr | ₹640 Cr +168% | |
| Net Income | −₹48.8 Cr | −₹7.2 Cr | ₹97.5 Cr | ₹14.3 Cr | ₹14.3 Cr -442% | |
| Total Assets | ₹2,365 Cr | ₹1,262 Cr | ₹11,923 Cr | ₹1,424 Cr | ₹1,424 Cr +66% | |
| EPS | ₹-3.96 | ₹-0.88 | ₹6.22 | ₹4.36 | ₹4.36 -191% | |
| Book Value per Share | ₹97.07 | ₹135.22 | ₹425.82 | ₹112.07 | ₹135.22 -28% | |